Annual FCF
-$19.47 M
+$3.89 M+16.65%
31 December 2023
Summary:
Imunon annual free cash flow is currently -$19.47 million, with the most recent change of +$3.89 million (+16.65%) on 31 December 2023. During the last 3 years, it has fallen by -$3.84 million (-24.53%). IMNN annual FCF is now -962.82% below its all-time high of $2.26 million, reached on 01 December 2008.IMNN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$4.06 M
+$446.30 K+9.91%
30 September 2024
Summary:
Imunon quarterly free cash flow is currently -$4.06 million, with the most recent change of +$446.30 thousand (+9.91%) on 30 September 2024. Over the past year, it has increased by +$655.20 thousand (+13.90%). IMNN quarterly FCF is now -136.00% below its all-time high of $11.27 million, reached on 01 June 2008.IMNN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$18.22 M
+$655.20 K+3.47%
30 September 2024
Summary:
Imunon TTM free cash flow is currently -$18.22 million, with the most recent change of +$655.20 thousand (+3.47%) on 30 September 2024. Over the past year, it has increased by +$2.53 million (+12.21%). IMNN TTM FCF is now -635.75% below its all-time high of $3.40 million, reached on 01 March 2009.IMNN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMNN Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.6% | +13.9% | +12.2% |
| 3 y3 years | -24.5% | -5.5% | -20.2% |
| 5 y5 years | -171.2% | +10.9% | -103.6% |
IMNN Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -24.5% | +16.6% | -7.6% | +49.5% | -20.2% | +22.2% |
| 5 y | 5 years | -171.2% | +16.6% | -49.6% | +49.5% | -103.6% | +22.2% |
| alltime | all time | -962.8% | +16.6% | -136.0% | +49.5% | -635.8% | +26.7% |
Imunon Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.06 M(-9.9%) | -$18.22 M(-3.5%) |
| June 2024 | - | -$4.50 M(-23.5%) | -$18.88 M(-11.5%) |
| Mar 2024 | - | -$5.89 M(+56.0%) | -$21.32 M(+9.5%) |
| Dec 2023 | -$19.47 M(-16.7%) | -$3.77 M(-20.0%) | -$19.47 M(-6.2%) |
| Sept 2023 | - | -$4.71 M(-32.2%) | -$20.75 M(+0.1%) |
| June 2023 | - | -$6.95 M(+72.0%) | -$20.74 M(+7.0%) |
| Mar 2023 | - | -$4.04 M(-20.0%) | -$19.37 M(-17.1%) |
| Dec 2022 | -$23.36 M(+41.3%) | -$5.05 M(+7.6%) | -$23.36 M(-0.3%) |
| Sept 2022 | - | -$4.70 M(-15.9%) | -$23.43 M(+3.8%) |
| June 2022 | - | -$5.58 M(-30.5%) | -$22.57 M(+14.6%) |
| Mar 2022 | - | -$8.03 M(+57.1%) | -$19.70 M(+19.2%) |
| Dec 2021 | -$16.54 M(+5.7%) | - | - |
| Dec 2021 | - | -$5.11 M(+33.0%) | -$16.54 M(+9.1%) |
| Sept 2021 | - | -$3.85 M(+41.7%) | -$15.16 M(-0.8%) |
| June 2021 | - | -$2.71 M(-44.2%) | -$15.28 M(-1.5%) |
| Mar 2021 | - | -$4.86 M(+30.2%) | -$15.52 M(-0.8%) |
| Dec 2020 | -$15.64 M(-24.1%) | -$3.74 M(-5.8%) | -$15.64 M(-10.8%) |
| Sept 2020 | - | -$3.97 M(+34.4%) | -$17.53 M(-3.2%) |
| June 2020 | - | -$2.95 M(-40.8%) | -$18.12 M(-9.0%) |
| Mar 2020 | - | -$4.98 M(-11.5%) | -$19.91 M(-3.4%) |
| Dec 2019 | -$20.61 M(+187.0%) | -$5.63 M(+23.6%) | -$20.61 M(+130.3%) |
| Sept 2019 | - | -$4.55 M(-4.0%) | -$8.95 M(+3.3%) |
| June 2019 | - | -$4.74 M(-16.5%) | -$8.66 M(+6.0%) |
| Mar 2019 | - | -$5.68 M(-194.2%) | -$8.18 M(+13.9%) |
| Dec 2018 | -$7.18 M(-57.0%) | $6.03 M(-241.2%) | -$7.18 M(-58.8%) |
| Sept 2018 | - | -$4.27 M(+0.4%) | -$17.44 M(-4.6%) |
| June 2018 | - | -$4.25 M(-9.2%) | -$18.27 M(+0.3%) |
| Mar 2018 | - | -$4.68 M(+10.8%) | -$18.21 M(+9.2%) |
| Dec 2017 | -$16.68 M(-9.5%) | -$4.23 M(-17.2%) | -$16.68 M(-2.6%) |
| Sept 2017 | - | -$5.11 M(+21.7%) | -$17.13 M(+2.3%) |
| June 2017 | - | -$4.20 M(+33.2%) | -$16.75 M(-0.4%) |
| Mar 2017 | - | -$3.15 M(-32.6%) | -$16.83 M(-8.8%) |
| Dec 2016 | -$18.44 M(-11.9%) | -$4.68 M(-1.1%) | -$18.44 M(+4.4%) |
| Sept 2016 | - | -$4.73 M(+10.7%) | -$17.67 M(-3.5%) |
| June 2016 | - | -$4.27 M(-10.4%) | -$18.31 M(-7.2%) |
| Mar 2016 | - | -$4.77 M(+22.2%) | -$19.73 M(-5.8%) |
| Dec 2015 | -$20.94 M(-4.9%) | -$3.90 M(-27.4%) | -$20.94 M(-12.1%) |
| Sept 2015 | - | -$5.37 M(-5.5%) | -$23.82 M(-3.0%) |
| June 2015 | - | -$5.69 M(-4.9%) | -$24.56 M(+6.0%) |
| Mar 2015 | - | -$5.98 M(-11.9%) | -$23.18 M(+5.3%) |
| Dec 2014 | -$22.03 M(+129.8%) | -$6.78 M(+10.9%) | -$22.03 M(+17.7%) |
| Sept 2014 | - | -$6.12 M(+42.1%) | -$18.71 M(+22.6%) |
| June 2014 | - | -$4.30 M(-10.8%) | -$15.25 M(-5.8%) |
| Mar 2014 | - | -$4.82 M(+39.1%) | -$16.20 M(+69.0%) |
| Dec 2013 | -$9.58 M(-57.9%) | -$3.47 M(+30.2%) | -$9.58 M(-22.3%) |
| Sept 2013 | - | -$2.66 M(-49.2%) | -$12.33 M(-17.4%) |
| June 2013 | - | -$5.24 M(-393.0%) | -$14.93 M(-0.9%) |
| Mar 2013 | - | $1.79 M(-128.8%) | -$15.06 M(-33.8%) |
| Dec 2012 | -$22.76 M(-2.4%) | -$6.21 M(+18.0%) | -$22.76 M(+7.2%) |
| Sept 2012 | - | -$5.26 M(-2.1%) | -$21.23 M(-7.8%) |
| June 2012 | - | -$5.38 M(-8.9%) | -$23.02 M(-7.4%) |
| Mar 2012 | - | -$5.91 M(+26.1%) | -$24.85 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$23.32 M(+74.3%) | -$4.68 M(-33.6%) | -$23.32 M(+8.9%) |
| Sept 2011 | - | -$7.05 M(-2.2%) | -$21.41 M(+18.0%) |
| June 2011 | - | -$7.21 M(+64.8%) | -$18.14 M(+23.3%) |
| Mar 2011 | - | -$4.37 M(+57.6%) | -$14.72 M(+10.0%) |
| Dec 2010 | -$13.37 M(+1153.9%) | -$2.77 M(-26.8%) | -$13.37 M(-6.3%) |
| Sept 2010 | - | -$3.79 M(+0.2%) | -$14.27 M(-8.2%) |
| June 2010 | - | -$3.78 M(+24.7%) | -$15.54 M(+1419.1%) |
| Mar 2010 | - | -$3.03 M(-17.5%) | -$1.02 M(-4.1%) |
| Dec 2009 | -$1.07 M(-147.3%) | -$3.67 M(-27.4%) | -$1.07 M(-182.1%) |
| Sept 2009 | - | -$5.06 M(-147.1%) | $1.30 M(-54.7%) |
| June 2009 | - | $10.74 M(-449.1%) | $2.86 M(-15.8%) |
| Mar 2009 | - | -$3.08 M(+135.2%) | $3.40 M(+50.7%) |
| Dec 2008 | $2.26 M(-120.0%) | -$1.31 M(-62.5%) | $2.26 M(+120.1%) |
| Sept 2008 | - | -$3.49 M(-131.0%) | $1.03 M(-264.3%) |
| June 2008 | - | $11.27 M(-367.2%) | -$624.30 K(-95.6%) |
| Mar 2008 | - | -$4.22 M(+66.2%) | -$14.03 M(+24.5%) |
| Dec 2007 | -$11.27 M(+50.4%) | -$2.54 M(-50.6%) | -$11.27 M(+13.9%) |
| Sept 2007 | - | -$5.14 M(+141.0%) | -$9.90 M(+48.3%) |
| June 2007 | - | -$2.13 M(+45.8%) | -$6.68 M(-15.2%) |
| Mar 2007 | - | -$1.46 M(+25.3%) | -$7.87 M(+5.1%) |
| Dec 2006 | -$7.50 M(-8.3%) | -$1.17 M(-39.1%) | -$7.50 M(+3.1%) |
| Sept 2006 | - | -$1.92 M(-42.4%) | -$7.27 M(-2.0%) |
| June 2006 | - | -$3.33 M(+207.0%) | -$7.42 M(+17.6%) |
| Mar 2006 | - | -$1.08 M(+14.8%) | -$6.31 M(-22.8%) |
| Dec 2005 | -$8.17 M(-43.3%) | -$944.20 K(-54.2%) | -$8.17 M(-23.6%) |
| Sept 2005 | - | -$2.06 M(-7.1%) | -$10.70 M(-14.2%) |
| June 2005 | - | -$2.22 M(-24.8%) | -$12.46 M(-14.1%) |
| Mar 2005 | - | -$2.95 M(-15.0%) | -$14.50 M(+0.5%) |
| Dec 2004 | -$14.43 M(+56.8%) | -$3.47 M(-9.3%) | -$14.43 M(+3.8%) |
| Sept 2004 | - | -$3.83 M(-10.1%) | -$13.90 M(+7.5%) |
| June 2004 | - | -$4.26 M(+48.0%) | -$12.93 M(+20.9%) |
| Mar 2004 | - | -$2.88 M(-2.3%) | -$10.70 M(+4.2%) |
| Dec 2003 | - | -$2.94 M(+3.0%) | -$10.26 M(+11.5%) |
| Sept 2003 | -$9.20 M(-0.0%) | -$2.86 M(+41.5%) | -$9.20 M(+7.7%) |
| June 2003 | - | -$2.02 M(-17.3%) | -$8.54 M(-4.7%) |
| Mar 2003 | - | -$2.44 M(+29.8%) | -$8.96 M(-2.6%) |
| Dec 2002 | - | -$1.88 M(-14.3%) | -$9.20 M(-0.1%) |
| Sept 2002 | -$9.20 M(+45.1%) | -$2.20 M(-9.9%) | -$9.20 M(+2.8%) |
| June 2002 | - | -$2.44 M(-9.1%) | -$8.95 M(+10.4%) |
| Mar 2002 | - | -$2.68 M(+42.2%) | -$8.11 M(+17.7%) |
| Dec 2001 | - | -$1.89 M(-2.9%) | -$6.89 M(+8.6%) |
| Sept 2001 | -$6.34 M(+59.0%) | -$1.94 M(+21.8%) | -$6.34 M(+22.9%) |
| June 2001 | - | -$1.60 M(+9.0%) | -$5.16 M(+10.0%) |
| Mar 2001 | - | -$1.46 M(+9.3%) | -$4.69 M(+13.7%) |
| Dec 2000 | - | -$1.34 M(+75.4%) | -$4.13 M(+3.5%) |
| Sept 2000 | -$3.99 M(+73.4%) | -$763.30 K(-32.3%) | -$3.99 M(+23.7%) |
| June 2000 | - | -$1.13 M(+25.5%) | -$3.23 M(+53.7%) |
| Mar 2000 | - | -$898.10 K(-25.2%) | -$2.10 M(+74.8%) |
| Dec 1999 | - | -$1.20 M | -$1.20 M |
| Sept 1999 | -$2.30 M(+7.8%) | - | - |
| Sept 1998 | -$2.13 M(+84.2%) | - | - |
| Sept 1997 | -$1.16 M(-21.3%) | - | - |
| Sept 1996 | -$1.47 M | - | - |
FAQ
- What is Imunon annual free cash flow?
- What is the all time high annual FCF for Imunon?
- What is Imunon annual FCF year-on-year change?
- What is Imunon quarterly free cash flow?
- What is the all time high quarterly FCF for Imunon?
- What is Imunon quarterly FCF year-on-year change?
- What is Imunon TTM free cash flow?
- What is the all time high TTM FCF for Imunon?
- What is Imunon TTM FCF year-on-year change?
What is Imunon annual free cash flow?
The current annual FCF of IMNN is -$19.47 M
What is the all time high annual FCF for Imunon?
Imunon all-time high annual free cash flow is $2.26 M
What is Imunon annual FCF year-on-year change?
Over the past year, IMNN annual free cash flow has changed by +$3.89 M (+16.65%)
What is Imunon quarterly free cash flow?
The current quarterly FCF of IMNN is -$4.06 M
What is the all time high quarterly FCF for Imunon?
Imunon all-time high quarterly free cash flow is $11.27 M
What is Imunon quarterly FCF year-on-year change?
Over the past year, IMNN quarterly free cash flow has changed by +$655.20 K (+13.90%)
What is Imunon TTM free cash flow?
The current TTM FCF of IMNN is -$18.22 M
What is the all time high TTM FCF for Imunon?
Imunon all-time high TTM free cash flow is $3.40 M
What is Imunon TTM FCF year-on-year change?
Over the past year, IMNN TTM free cash flow has changed by +$2.53 M (+12.21%)